Anavo Therapeutics

Anavo-Therapeutics

Anavo’s mission is to pioneer systematic drug discovery and development approaches aimed at phosphatases, a rich and largely untapped therapeutic target class. Anavo’s approach focuses on combining profound understanding of phosphatase biology with deep drug discovery expertise and state-of-the-art technologies to design first-in-class and best-in-class small molecule modulators of phosphatase activity.

Location: Leiden (The Netherlands) and Heidelberg (Germany)
Board director: Debora Dumont
Board observer: Joris De Maeyer
Website:

Related news